HomeAI · summaries
Storia in 8 fonti
Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth
In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and more
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Three biotechs with three news updates
Gilead wins case over its HIV medicine, Eli Lilly to expand retatrutide access, and more biotech news
- ·
forbes.com
Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth
In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and more
